Cancer Biology & Medicine: 22 (11)

November 15, 2025; Volume 22,Issue 11

Perspectives

Open Access
Chromatin relaxation dynamics and histone PTMs in the early DNA damage response
Jinqin Qian, Zhongyi Xie, Liqun Zhou and Wei-Guo Zhu

Cancer Biology & Medicine November 2025, 22 (11) 1267-1274; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0369
Open Access
Immunological and metabolic optimization of tumor neoantigen vaccines
Xiafeng Wang, Zhangping Huang, Lin Peng, Shuoxi Xu, Jianfeng Huang and Ji Wang

Cancer Biology & Medicine November 2025, 22 (11) 1275-1281; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0445

Reviews

Open Access
Neutrophil extracellular traps and metabolic reprogramming in renal cell carcinoma: implications for tumor progression and immune-based therapeutics
Asif Shahzad, Yueli Ni, Zhuoran Teng, Wenjing Liu, Honggang Bai, Yijian Sun, Kun Cui, Qiuxin Duan, Xiangjie Liu, Zhe Xu, Jinshan Zhang, Jiaojiao Xia, Rong Che, Ting Guo, Zhe Yang and Qiao Zhang

Cancer Biology & Medicine November 2025, 22 (11) 1282-1303; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0219
Open Access
Biological mechanism and immune response of MHC-II expression in tumor cells
Mengya Zhou, Siwei Pan, Yanqiang Zhang, Can Hu and Zhiyuan Xu

Cancer Biology & Medicine November 2025, 22 (11) 1304-1326; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0248
Open Access
Unraveling vascular mechanisms in melanoma: roles of angiogenesis and vasculogenic mimicry in tumor progression and therapeutic resistance
Simona Serratì, Lucia Raho, Gisella De Giosa, Letizia Porcelli, Roberta Di Fonte, Rossella Fasano, Pedro Miguel Lacal, Grazia Graziani, Rosa Maria Iacobazzi and Amalia Azzariti

Cancer Biology & Medicine November 2025, 22 (11) 1327-1352; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0048
Open Access
Research progress and challenges in the treatment of oncogene-addicted non-small cell lung cancer
Hanyi Li, Xuanguang Li, Tong Li, Fan Ren, Haochuan Yu, Dianxun Fu, Zuoqing Song and Song Xu

Cancer Biology & Medicine November 2025, 22 (11) 1353-1371; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0153

Letters

Open Access
IL-17A blockade alleviates immune checkpoint inhibitor-associated psoriasiform rash: preclinical and clinical responses
Yuli Ruan, Mengde Shi, Yue Ma, Bojun Wang, Ming Ma, Tianjiao Dang, Yanqiao Zhang and Chao Liu

Cancer Biology & Medicine November 2025, 22 (11) 1372-1376; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0344
Open Access
Phase I clinical study of humanized BCMA-single-domain antibodies targeting CAR-T in patients with relapsed or refractory multiple myeloma
Gaofeng Zheng, Ruyi Xu, Heng Mei, Xiaoyan Han, Donghua He, Yanling Weng, Cheng Wen, Zhuoxiao Cao and Zhen Cai

Cancer Biology & Medicine November 2025, 22 (11) 1377-1380; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0581

Original Articles

Open Access
A novel biguanide-derivative promotes NEDD4-mediated FGFR1 ubiquitination through BMI1 to overcome osimertinib resistance in NSCLC
Mei Peng, Weifan Wang, Di Xiao, Duo Li, Jun Deng, Hui Zou, Xing Feng, Yunhai Yang, Songqing Fan and Xiaoping Yang

Cancer Biology & Medicine November 2025, 22 (11) 1381-1404; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0209
Open Access
Integrated pretreatment stratification system for pancreatic cancer: combining anatomical resectability and tumor biological parameters
Song Gao, Yuexiang Liang, Jun Yu, Shaofei Chang, Hongwei Wang, Tiansuo Zhao, Xiuchao Wang, Quan Man, Zhifei Li, Yiping Zou, Kuirong Jiang, Chuntao Gao and Jihui Hao

Cancer Biology & Medicine November 2025, 22 (11) 1405-1422; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0213

Main menu

User menu

Search

Table of Contents

Perspectives

Reviews

Letters

Original Articles

In this issue

Jump to

Navigate

More Information

For Authors

Journal Services